0001503274-25-000042 Sample Contracts
FORM OF REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 4th, 2025 • Quanterix Corp • Laboratory analytical instruments • Delaware
Contract Type FiledApril 4th, 2025 Company Industry JurisdictionThis Registration Rights Agreement (this “Agreement”) is made and entered into as of [●], by and between Akoya Biosciences, Inc., a Delaware corporation (the “Company”), and Quanterix Corporation (the “Holder”). The Company and the Holder are referred to each as a “Party” and collectively herein as the “Parties.” Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement.
FORM OF SUBORDINATION AGREEMENTSubordination Agreement • April 4th, 2025 • Quanterix Corp • Laboratory analytical instruments • New York
Contract Type FiledApril 4th, 2025 Company Industry JurisdictionThis SUBORDINATION AGREEMENT (this “Agreement”) is entered into as of this [●] day of [●], 202[●], by and among QUANTERIX CORPORATION, a Delaware corporation (“Subordinated Lender”), AKOYA BIOSCIENCES, INC., a Delaware corporation (“Borrower”), and MIDCAP FINANCIAL TRUST, a Delaware statutory trust, as Agent for the financial institutions or other entities from time to time parties to the Senior Loan Agreement (as hereinafter defined) (acting in such capacity, “Agent”), and as a Lender, or such then present holder or holders of the Senior Loan (as hereinafter defined) as may from time to time exist (the “Lenders,” and collectively with the Agent, the “Senior Lenders”).
SECURITIES PURCHASE AGREEMENT BY AND BETWEEN QUANTERIX CORPORATION AND AKOYA BIOSCIENCES, INC. Dated as of April 2, 2025Securities Purchase Agreement • April 4th, 2025 • Quanterix Corp • Laboratory analytical instruments • Delaware
Contract Type FiledApril 4th, 2025 Company Industry JurisdictionTHIS SECURITIES PURCHASE AGREEMENT (together with all Exhibits and Schedules hereto, as each may be amended, restated, amended and restated, supplemented or otherwise modified from time to time in accordance with the terms hereof, this “Agreement”), dated as of April 1, 2025, is made by and between (i) Akoya Biosciences, Inc., a Delaware corporation (the “Company”), and (ii) Quanterix Corporation, a Delaware corporation (“Purchaser”). The Company and Purchaser are referred to herein individually as a “Party,” and, collectively as the “Parties.” Capitalized terms used herein and not otherwise defined herein are defined in Article I hereof.
